ARTICLE | Management Tracks
Plus: Glasspool to lead VarmX, Novartis vet Eissa joins Cellares and updates from Mestag, Andera, Incyclix and more
By BioCentury Staff
November 14, 2024 1:03 AM UTC
Flagship Pioneering-backed Valo Health Inc. and Apriori Bio Inc. named CEOs, both of whom also become CEO-partner at the VC. Brian Alexander joined Valo, where he succeeds interim CEO Graeme Bell, and Craig Williams was promoted to CEO from his positions as Flagship operating partner and Apriori president. Alexander was SVP for R&D at Genentech Inc. Apriori aims to end the viral variant chasing that has prevented vaccine and therapeutic developers from keeping pace with evolving pathogenic threats; Valo is using AI to discover and develop therapeutics.
Valo also named Brett Blackman COO and appointed Travis Wilson to its board. Blackman co-founded Valo and was its CBO and chief innovation officer; Wilson was president and CEO of Stealth BioTherapeutics Inc…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654185/new-ceos-at-valo-apriori